April 5, 20100Immune-Based Treatments for Brain Cancer Post Impressive Early-Stage Results Approximately 19,000 individuals in the US are diagnosed with primary brain cancers each year.
October 12, 20090Positive Phase II Data for Peregrine’s Lung Cancer Treatment Peregrine Pharmaceuticals reported positive Phase II data in a clinical trial of bavituximab in patients with a deadly form of lung cancer.
